Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
53511 | Guangdong King-Strong Technology Co Ltd (300629.SZ) | XSHE | CN | 2022-12-31 | 4 days ago | CNY | 18.16 | 5.63 | 30.99% | 2.00 | 11.02% | NCAV (Net-Net) | 2.00 | 11.02% |
53512 | Hainan Poly Pharm Co Ltd (300630.SZ) | XSHE | CN | 2022-12-31 | 4 days ago | CNY | 14.51 | 11.76 | 81.05% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
53513 | Xiamen Guang Pu Electronics Co Ltd (300632.SZ) | XSHE | CN | 2022-12-31 | 4 days ago | CNY | 9.08 | 6.78 | 74.70% | 4.44 | 48.87% | NCAV (Net-Net) | 4.44 | 48.87% |
53514 | SonoScape Medical Corp (300633.SZ) | XSHE | CN | 2022-12-31 | 4 days ago | CNY | 36.97 | 8.08 | 21.85% | 4.00 | 10.81% | NCAV (Net-Net) | 4.00 | 10.81% |
53515 | SinoDaan Co Ltd (300635.SZ) | XSHE | CN | 2022-12-31 | 4 days ago | CNY | 8.08 | 0.00 | 0.00% | 1.02 | 12.65% | Ungraded | 0.00 | 0.00% |
53516 | Jiangxi Synergy Pharmaceutical Co Ltd (300636.SZ) | XSHE | CN | 2022-12-31 | 4 days ago | CNY | 9.16 | 5.06 | 55.20% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
53517 | Zhejiang Yangfan New Materials Co Ltd (300637.SZ) | XSHE | CN | 2022-12-31 | 4 days ago | CNY | 6.96 | 2.03 | 29.16% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
53518 | Profit Cultural and Creative Group Co Ltd (300640.SZ) | XSHE | CN | 2022-12-31 | 4 days ago | CNY | 4.24 | 2.93 | 69.08% | 0.94 | 22.06% | NCAV (Net-Net) | 0.94 | 22.06% |
53519 | Jiangsu Zhengdan Chemical Industry Co Ltd (300641.SZ) | XSHE | CN | 2022-12-31 | 4 days ago | CNY | 13.10 | 3.12 | 23.83% | 1.68 | 12.81% | NCAV (Net-Net) | 1.68 | 12.81% |
53520 | Tellgen Corp (300642.SZ) | XSHE | CN | 2022-12-31 | 4 days ago | CNY | 12.55 | 14.48 | 115.40% | 5.30 | 42.21% | NCAV (Net-Net) | 5.30 | 42.21% |